Mylan Pharma has launched the drug under its collaboration pact with Coastal Pharmaceuticals.
The drug is the generic version of Endo Pharmaceuticals‘ Percodan tablets, used as a treatment for moderate to severe pain.
Percodan tablets contain a mixture of 325mg of aspirin and 4.8355mg of oxycodone HCl (equivalent to 4.3346 mg of oxycodone as the free base).